BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 31974902)

  • 1. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
    Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
    J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 4. Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019.
    Advani S; Zhang D; Tammemagi M; Akinyemiju T; Gould MK; Silvestri GA; Braithwaite D
    Ann Am Thorac Soc; 2021 Nov; 18(11):1886-1893. PubMed ID: 33939595
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study.
    Silvestri GA; Goldman L; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Tanner NT; Fedewa S
    Ann Intern Med; 2022 Nov; 175(11):1501-1505. PubMed ID: 36215712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.
    Pinsky PF; Gierada DS; Hocking W; Patz EF; Kramer BS
    Ann Intern Med; 2014 Nov; 161(9):627-33. PubMed ID: 25199624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
    Li J; Chung S; Wei EK; Luft HS
    BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
    Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
    JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
    Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
    Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
    Kim EY; Shim YS; Kim YS; Lee SP; Ko KD; Choi WJ
    PLoS One; 2019; 14(10):e0224224. PubMed ID: 31639166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study.
    Rendle KA; Saia CA; Vachani A; Burnett-Hartman AN; Doria-Rose VP; Beucker S; Neslund-Dudas C; Oshiro C; Kim RY; Elston-Lafata J; Honda SA; Ritzwoller D; Wainwright JV; Mitra N; Greenlee RT
    Ann Intern Med; 2024 Jan; 177(1):18-28. PubMed ID: 38163370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with adherence to provider referrals for lung cancer screening with low dose computed tomography before and during COVID-19 pandemic.
    Li J; Stults CD; Liang SY; Martinez M
    BMC Cancer; 2023 Aug; 23(1):809. PubMed ID: 37644406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study.
    Braithwaite D; Karanth SD; Slatore CG; Zhang D; Bian J; Meza R; Jeon J; Tammemagi M; Schabath M; Wheeler M; Guo Y; Hochhegger B; Kaye FJ; Silvestri GA; Gould MK
    BMJ Open; 2022 Jun; 12(6):e064142. PubMed ID: 35732383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.
    Pallin M; Walsh S; O'Driscoll MF; Murray C; Cahalane A; Brown L; Carter M; Mitchell P; McDonnell TJ; Butler MW
    Lung; 2012 Dec; 190(6):621-8. PubMed ID: 23064487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium.
    Neslund-Dudas C; Tang A; Alleman E; Zarins KR; Li P; Simoff MJ; Lafata JE; Rendle KA; Hartman ANB; Honda SA; Oshiro C; Olaiya O; Greenlee RT; Vachani A; Ritzwoller DP
    J Gen Intern Med; 2024 Feb; 39(2):186-194. PubMed ID: 37783984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDCT lung cancer screening in populations at different risk for lung cancer.
    Teles GBDS; Macedo ACS; Chate RC; Valente VAT; Funari MBG; Szarf G
    BMJ Open Respir Res; 2020 Feb; 7(1):. PubMed ID: 33371010
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.